Enterococcus: Difference between revisions
From IDWiki
Enterococcus
m (Text replacement - "[[Cellular shape::" to "[[Shape::") |
No edit summary |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 13: | Line 13: | ||
===Species=== |
===Species=== |
||
* |
*[[Enterococcus faecalis]] |
||
**More common (90-95%) |
**More common (90-95%) |
||
**More commonly genitourinary source |
**More commonly genitourinary source |
||
**More susceptible to antibiotics |
**More susceptible to antibiotics |
||
* |
*[[Enterococcus faecium]] |
||
**Less common (5-10%) |
**Less common (5-10%) |
||
**More commonly gastrointestinal source |
**More commonly gastrointestinal source |
||
**Less susceptible to antibiotics |
**Less susceptible to antibiotics |
||
**Most common VRE |
**Most common VRE |
||
*[[Enterococcus avium]] |
|||
* |
*[[Enterococcus gallinarum]] |
||
* |
*[[Enterococcus casseliflavus]] |
||
*[[Enterococcus hirae]], a rare zoonotic pathogen from chickens that can cause [[bacteremia]] and [[endocarditis]] |
|||
=== |
===Vancomycin Resistance=== |
||
*Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis |
*Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis |
||
| Line 33: | Line 35: | ||
==Management== |
==Management== |
||
* [[Vancomycin]] is usually reliable (except for [[Enterococcus gallinarum]] and [[Enterococcus casseliflavus]]) |
|||
* [[Ampicillin]] is preferred for susceptible strains |
|||
* Inherent resistance to [[cephalosporins]] |
|||
* Resistant to [[ertapenem]], but ampicillin-susceptible strains are often susceptible to [[imipenem]] and (less reliably) to [[meropenem]] |
|||
===VRE=== |
===VRE=== |
||
*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'') |
*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'') |
||
*For VanC isolates, [[ampicillin]] or [[penicillin]] is preferred, and [[daptomycin]] susceptibility is often retained[[CiteRef::jorgensen2003in]] |
|||
{{DISPLAYTITLE:''Enterococcus'' |
{{DISPLAYTITLE:''Enterococcus''}} |
||
[[Category:Gram-positive cocci]] |
[[Category:Gram-positive cocci]] |
||
Latest revision as of 20:36, 23 September 2024
Background
Microbiology
- Genus of facultative anaerobic, non-spore-forming, alpha- or gamma-hemolytic, catalase negative, Gram-positive cocci
- Grows on bile esculin agar
- PYR positive
- Most are Lancefield group D
- Commensal gut flora
- Increasing antibiotic resistance
Species
- Enterococcus faecalis
- More common (90-95%)
- More commonly genitourinary source
- More susceptible to antibiotics
- Enterococcus faecium
- Less common (5-10%)
- More commonly gastrointestinal source
- Less susceptible to antibiotics
- Most common VRE
- Enterococcus avium
- Enterococcus gallinarum
- Enterococcus casseliflavus
- Enterococcus hirae, a rare zoonotic pathogen from chickens that can cause bacteremia and endocarditis
Vancomycin Resistance
- Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
- VanA: most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
- VanB: more common in E. faecium in Australia
- VanC: chromosomal resistance on E. gallinarum and E. casseliflavus
Management
- Vancomycin is usually reliable (except for Enterococcus gallinarum and Enterococcus casseliflavus)
- Ampicillin is preferred for susceptible strains
- Inherent resistance to cephalosporins
- Resistant to ertapenem, but ampicillin-susceptible strains are often susceptible to imipenem and (less reliably) to meropenem
VRE
- Daptomycin, doxycycline, linezolid, tedizolid, oritavancin, quinupristin-dalfopristin (for E. faecium)
- For VanC isolates, ampicillin or penicillin is preferred, and daptomycin susceptibility is often retained1
References
- ^ James H. Jorgensen, Sharon A. Crawford, Cynthia C. Kelly, Jan E. Patterson. In VitroActivity of Daptomycin against Vancomycin-Resistant Enterococci ofVarious Van Types and Comparison of Susceptibility TestingMethods. Antimicrobial Agents and Chemotherapy. 2003;47(12):3760-3763. doi:10.1128/aac.47.12.3760-3763.2003.
